Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment.
Ontology highlight
ABSTRACT: Estimation of susceptibility differences in human health risk assessment (HHRA) has been challenged by a lack of available susceptibility and variability data after exposure to a specific environmental chemical or pharmaceutical. With the increasingly large number of available data sources that contain polymorphism and other genetic data, human genetic variability that informs susceptibility can be better incorporated into HHRA. A recent policy, the 2016 The Frank R. Lautenberg Chemical Safety for the twenty-first Century Act, requires the US Environmental Protection Agency to evaluate new and existing toxic chemicals with explicit consideration of susceptible populations of all types (life stage, exposure, genetic, etc.). We propose using the adverse outcome pathway (AOP) construct to org
SUBMITTER: Mortensen HM
PROVIDER: S-EPMC9074075 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA